Cineline Intrinsic Value
Cineline (CINELINE) median intrinsic value is ₹131.76 from 3 valuation models (range ₹84–₹217), vs current price ₹86.71 — +52.0% upside (Trading Below Calculated Value), margin of safety 34.2%. For current market price and key ratios, visit Cineline stock price NSE.
CINELINE Valuation Methods Summary — DCF, Graham Number & P/E
Cineline intrinsic value across 3 models vs current price ₹86.71 — upside/downside and value range per method. Read Cineline dividend policy for the complete payout history and dividend yield track record.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| Book Value Method | asset | ₹84.12 | ₹75.71 - ₹92.53 | -3.0% | Book Value/Share: ₹84.12, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹131.76 | ₹118.58 - ₹144.94 | +52.0% | Revenue/Share: ₹131.76, P/S: 1.0x |
| Simple DCF (5Y) | dcf | ₹216.77 | ₹173.42 - ₹260.12 | +150.0% | CF Growth: 15.0%, Discount: 15% |
CINELINE Intrinsic Value vs Market Price — All Valuation Models
Cineline fair value range ₹84–₹217 vs current market price ₹86.71 across 3 valuation models. Analyse CINELINE shareholder distribution to track promoter, FII and institutional holdings.
CINELINE Intrinsic Value Analysis — Undervalued or Overvalued?
Cineline median intrinsic value ₹131.76, current price ₹86.71 — Trading Below Calculated Value by 52.0%, margin of safety 34.2%.
What is the intrinsic value of CINELINE?
Based on our comprehensive analysis using 3 different valuation methods, the estimated intrinsic value of Cineline (CINELINE) is ₹131.76 (median value). With the current market price of ₹86.71, this represents a +52.0% variance from our estimated fair value.
The valuation range spans from ₹84.12 to ₹216.77, indicating ₹84.12 - ₹216.77.
Is CINELINE undervalued or overvalued?
Based on our multi-method analysis, Cineline (CINELINE) appears to be trading below calculated value by approximately 52.0%.
CINELINE Financial Health — Key Ratios vs Industry Benchmarks
Cineline financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 0.51 | Industry Standard: 2.0+ | Below 1.5 | Measures short-term liquidity capacity |
| Return on Equity | -36.4% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | -32.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.71x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
CINELINE Cash Flow Quality — Operating & Free Cash Flow
Cineline operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹50 Cr | ₹50 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹42 Cr | ₹35 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹76 Cr | ₹76 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹10 Cr | ₹10 Cr | Positive Free Cash Flow | 8/10 |
| March 2021 | ₹-2 Cr | ₹-2 Cr | Negative Cash Flow | 3/10 |